Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» GlaxoSmithKline presents positive Phase III data for mepolizumab in severe asthma
GlaxoSmithKline presents positive Phase III data for mepolizumab in severe asthma
GlaxoSmithKline presents positive Phase III data for mepolizumab in severe asthma
Submitted by
admin
on March 12, 2014 - 3:22pm
Source:
First Word Pharma
News Tags:
GSK
mepolizumab
asthma
Headline:
GlaxoSmithKline presents positive Phase III data for mepolizumab in severe asthma
Do Not Allow Advertisers to Use My Personal information
